Advertisement

Topics

Akers Biosciences (NASDAQ: $AKER) (AIM: AKR.L) Announces Second Quarter Trading Update

02:00 EDT 3 Aug 2017 | InvestorIdeas

THOROFARE, NJ - August 3, 2017 (Investorideas.com Newswire) Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"), a developer of rapid health information technologies, announces that sales in the second quarter ended June 30, 2017 were among the strongest since the Company's admission to NASDAQ Capital Market in 2014.

Original Article: Akers Biosciences (NASDAQ: $AKER) (AIM: AKR.L) Announces Second Quarter Trading Update

NEXT ARTICLE

More From BioPortfolio on "Akers Biosciences (NASDAQ: $AKER) (AIM: AKR.L) Announces Second Quarter Trading Update"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...